Osteonecrosis of the jaw in patients treated by denosumab for malignant bone disease: descriptive study on 9 cases.

This study examines the epidemiological and clinical characteristics and therapeutic outcomes in patients with denosumab related-osteonecrosis of the jaw (DRONJ).Study design: The patients included are all being monitored by three oral and maxillofacial surgery departments for an osteonecrosis of the jaw (ONJ) linked to denosumab alone for the treatment of malignant bone disease between 2010 and 2016. Clinical and epidemiological data of these patients was indexed and characteristics of the DRONJ were analyzed.

from Imaging via alkiviadis.1961 on Inoreader https://ift.tt/2JUS1jN